Early research (Phase 1)UnknownNCT05475847What this trial is testingStudy of C-TIL052A Cell Therapy in Advanced Cervical CancerWho this might be right forCervical Cancer Fudan University 20
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT04974944What this trial is testingFirst-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical CancerWho this might be right forStage IVB Cervical CancerRecurrent Cervical CancerPersistent Cervical Cancer Sun Yat-sen University 172
Testing effectiveness (Phase 2)UnknownNCT05310331What this trial is testingDonafenib for Recurrent Cervical CancerWho this might be right forTargeted TherapyChemotherapyRecurrent Cervical Carcinoma+4 more Lei Li 20
Testing effectiveness (Phase 2)Study completedNCT00430781What this trial is testingPazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical CancerWho this might be right forNeoplasms, Uterine CervixMetastatic Cervical Cancer GlaxoSmithKline 228
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT06226350What this trial is testingA Phase Ⅱ Study of F520 in Patients With Cervical CarcinomaWho this might be right forCervical Cancer Shandong New Time Pharmaceutical Co., LTD 29
Testing effectiveness (Phase 2)UnknownNCT05290935What this trial is testingImmunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center TrialWho this might be right forRecurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more Lei Li 122
Testing effectiveness (Phase 2)Study completedNCT00002562What this trial is testingPaclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal CancerWho this might be right forCervical CancerVaginal Cancer Gynecologic Oncology Group 25
Testing effectiveness (Phase 2)Ended earlyNCT00138151What this trial is testingIsotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical CancerWho this might be right forCervical Cancer University of Medicine and Dentistry of New Jersey 33
Not applicableUnknownNCT05310305What this trial is testingPD-1 Antibody and Radiotherapy for Recurrent Cervical CancerWho this might be right forImmune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more Lei Li 20
Testing effectiveness (Phase 2)UnknownNCT05310383What this trial is testingTislelizumab and Radiotherapy for Recurrent Cervical CancerWho this might be right forRecurrent Cervical CarcinomaMetastatic Cervical CarcinomaPersistent Cervical Carcinoma+7 more Lei Li 58
Large-scale testing (Phase 3)WithdrawnNCT02446652What this trial is testingEvaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical CancerWho this might be right forCervical Cancer National Institute of Cancerología
Early research (Phase 1)Ended earlyNCT00322920What this trial is testingEfficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical CancerWho this might be right forCervix Cancer University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Ended earlyNCT04651127What this trial is testingAnti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical CancerWho this might be right forCervical CancerCervix CancerCervix Neoplasm Sun Yat-sen University 5
Testing effectiveness (Phase 2)Study completedNCT00276796What this trial is testingPaclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerWho this might be right forCervical Cancer Gynecologic Oncology Group 66
Testing effectiveness (Phase 2)Study completedNCT04188860What this trial is testingImmunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based ChemotherapyWho this might be right forRecurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+2 more Lei Li 34
Early research (Phase 1)Study completedNCT01281852What this trial is testingPaclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT07195734What this trial is testingTesting the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerWho this might be right forClinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell Carcinoma+15 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00016926What this trial is testingCapecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerWho this might be right forCervical Cancer Gynecologic Oncology Group